[ALNY] YoY Quarter Result on 30-Jun-2016 [#Q2]

Stock
[ALNY] Alnylam Pharmaceuticals, Inc.
Announcement Date
04-Aug-2016
Financial Year
2016
Quarter
30-Jun-2016 [#Q2]
Profit Trend
QoQ- 12.47%
YoY- -25.56%
Quarter Report
ALNY's Result
ALNY's Financial Summary
View:
Show?
Quarter Result
30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 CAGR
Revenue 44,714 29,907 15,932 8,709 8,685 7,295 8,687 31.38%
PBT -218,521 -163,481 -118,420 -90,129 -71,352 -44,389 -21,053 47.66%
Tax 960 79 -2,577 -2,092 431 -315 -2,884 -
NP -219,481 -163,560 -118,420 -90,129 -71,783 -44,074 -18,169 51.44%
Tax Rate - - - - - - - -
Total Cost 264,195 193,467 134,352 98,838 80,468 51,369 26,856 46.35%
Ratio Analysis
30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 CAGR
NP Margin -490.86 -546.90 -743.28 -1,034.89 -826.52 -604.17 -209.15 15.27%
Per Share
30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 CAGR
EPS -2.02 -1.63 -1.34 -1.05 -0.85 -0.58 -0.29 38.17%
EPS Diluted -2.02 -1.63 -1.34 -1.05 -0.85 -0.58 -0.29 38.17%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.